Inhibitory effects of ubiquitination of synoviolin by PADI4
- Authors:
- Satoko Aratani
- Hidetoshi Fujita
- Naoko Yagishita
- Yoshihisa Yamano
- Yukari Okubo
- Kusuki Nishioka
- Toshihiro Nakajima
-
Affiliations: Department of Locomotor Science, Institute of Medical Science, Tokyo Medical University, Tokyo 160‑8402, Japan, Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Kanagawa 216‑8512, Japan, Physician, Student and Researcher Support Center, Tokyo Medical University, Tokyo 160‑0023, Japan, Institute of Medical Science, Tokyo Medical University, Tokyo 160‑8402, Japan - Published online on: October 11, 2017 https://doi.org/10.3892/mmr.2017.7764
- Pages: 9203-9209
This article is mentioned in:
Abstract
Harris ED Jr: Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med. 322:1277–1289. 1990. View Article : Google Scholar : PubMed/NCBI | |
Feldmann M, Brennan FM and Maini RN: Rheumatoid arthritis. Cell. 85:307–310. 1996. View Article : Google Scholar : PubMed/NCBI | |
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al: 2010 Rheumatoid arthritis classification criteria: An American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. 62:2569–2581. 2010. View Article : Google Scholar : PubMed/NCBI | |
Gabriel SE: The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 27:269–281. 2001. View Article : Google Scholar : PubMed/NCBI | |
Smolen JS and Aletaha D: Rheumatoid arthritis therapy reappraisal: Strategies, opportunities and challenges. Nat Rev Rheumatol. 11:276–289. 2015. View Article : Google Scholar : PubMed/NCBI | |
Yang XJ: Multisite protein modification and intramolecular signaling. Oncogene. 24:1653–1662. 2005. View Article : Google Scholar : PubMed/NCBI | |
Yamada R, Suzuki A, Chang X and Yamamoto K: Citrullinated proteins in rheumatoid arthritis. Front Biosci. 10:54–64. 2005. View Article : Google Scholar : PubMed/NCBI | |
Martin-Mola E, Balsa A, Garcia-Vicuna R, Gómez-Reino J, González-Gay MA, Sanmartí R and Loza E: Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: A review. Rheumatol Int. 36:1043–1063. 2016. View Article : Google Scholar : PubMed/NCBI | |
Aggarwal R, Liao K, Nair R, Ringold S and Costenbader KH: Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Rheum. 61:1472–1483. 2009. View Article : Google Scholar : PubMed/NCBI | |
van Venrooij WJ and Pruijn GJ: Citrullination: A small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res. 2:249–251. 2000. View Article : Google Scholar : PubMed/NCBI | |
Tarcsa E, Marekov LN, Mei G, Melino G, Lee SC and Steinert PM: Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem. 271:30709–30716. 1996. View Article : Google Scholar : PubMed/NCBI | |
Vossenaar ER, Zendman AJ, van Venrooij WJ and Pruijn GJ: PAD, a growing family of citrullinating enzymes: Genes, features and involvement in disease. Bioessays. 25:1106–1118. 2003. View Article : Google Scholar : PubMed/NCBI | |
Klareskog L, Rönnelid J, Lundberg K, Padyukov L and Alfredsson L: Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol. 26:651–675. 2008. View Article : Google Scholar : PubMed/NCBI | |
Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB and van Venrooij WJ: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 101:273–281. 1998. View Article : Google Scholar : PubMed/NCBI | |
Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC and van Venrooij WJ: The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 43:155–163. 2000. View Article : Google Scholar : PubMed/NCBI | |
Mrabet D, Laadhar L, Haouet S, Sahli H, Zouari B, Makni S and Sellami S: Anomalies of intra-synovial citrullination: Is there any interest in the diagnosis of early rheumatoid arthritis? Rheumatol Int. 33:787–791. 2013. View Article : Google Scholar : PubMed/NCBI | |
Ikari K, Kuwahara M, Nakamura T, Momohara S, Hara M, Yamanaka H, Tomatsu T and Kamatani N: Association between PADI4 and rheumatoid arthritis: A replication study. Arthritis Rheum. 52:3054–3057. 2005. View Article : Google Scholar : PubMed/NCBI | |
Foulquier C, Sebbag M, Clavel C, Chapuy-Regaud S, Al Badine R, Méchin MC, Vincent C, Nachat R, Yamada M, Takahara H, et al: Peptidyl arginine deiminase type 2(PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum. 56:3541–3553. 2007. View Article : Google Scholar : PubMed/NCBI | |
Chang X, Xia Y, Pan J, Meng Q, Zhao Y and Yan X: PADI2 is significantly associated with rheumatoid arthritis. PLoS One. 8:e812592013. View Article : Google Scholar : PubMed/NCBI | |
Anzilotti C, Pratesi F, Tommasi C and Migliorini P: Peptidylarginine deiminase 4 and citrullination in health and disease. Autoimmun Rev. 9:158–160. 2010. View Article : Google Scholar : PubMed/NCBI | |
Jones JE, Causey CP, Knuckley B, Slack-Noyes JL and Thompson PR: Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential. Curr Opin Drug Discov Devel. 12:616–627. 2009.PubMed/NCBI | |
Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M, Nagasaki M, Nakayama-Hamada M, Kawaida R, Ono M, et al: Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet. 34:395–402. 2003. View Article : Google Scholar : PubMed/NCBI | |
Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, Tokuhiro S and Yamamoto K: Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford). 44:40–50. 2005. View Article : Google Scholar : PubMed/NCBI | |
Mastronardi FG, Wood DD, Mei J, Raijmakers R, Tseveleki V, Dosch HM, Probert L, Casaccia-Bonnefil P and Moscarello MA: Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: A role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation. J Neurosci. 26:11387–11396. 2006. View Article : Google Scholar : PubMed/NCBI | |
Cuthbert GL, Daujat S, Snowden AW, Erdjument-Bromage H, Hagiwara T, Yamada M, Schneider R, Gregory PD, Tempst P, Bannister AJ and Kouzarides T: Histone deimination antagonizes arginine methylation. Cell. 118:545–553. 2004. View Article : Google Scholar : PubMed/NCBI | |
Wang Y, Wysocka J, Sayegh J, Lee YH, Perlin JR, Leonelli L, Sonbuchner LS, McDonald CH, Cook RG, Dou Y, et al: Human PAD4 regulates histone arginine methylation levels via demethylimination. Science. 306:279–283. 2004. View Article : Google Scholar : PubMed/NCBI | |
Wang Y, Li M, Stadler S, Correll S, Li P, Wang D, Hayama R, Leonelli L, Han H, Grigoryev SA, et al: Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol. 184:205–213. 2009. View Article : Google Scholar : PubMed/NCBI | |
Li P, Li M, Lindberg MR, Kennett MJ, Xiong N and Wang Y: PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med. 207:1853–1862. 2010. View Article : Google Scholar : PubMed/NCBI | |
Tanikawa C, Ueda K, Nakagawa H, Yoshida N, Nakamura Y and Matsuda K: Regulation of protein Citrullination through p53/PADI4 network in DNA damage response. Cancer Res. 69:8761–8769. 2009. View Article : Google Scholar : PubMed/NCBI | |
Yoo SA, You S, Yoon HJ, Kim DH, Kim HS, Lee K, Ahn JH, Hwang D, Lee AS, Kim KJ, et al: A novel pathogenic role of the ER chaperone GRP78/BiP in rheumatoid arthritis. J Exp Med. 209:871–886. 2012. View Article : Google Scholar : PubMed/NCBI | |
Manié SN, Lebeau J and Chevet E: Cellular mechanisms of endoplasmic reticulum stress signaling in health and disease. 3. Orchestrating the unfolded protein response in oncogenesis: An update. Am J Physiol Cell Physiol. 307:C901–C907. 2014. View Article : Google Scholar : PubMed/NCBI | |
Hotamisligil GS and Erbay E: Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol. 8:923–934. 2008. View Article : Google Scholar : PubMed/NCBI | |
Park YJ, Yoo SA and Kim WU: Role of endoplasmic reticulum stress in rheumatoid arthritis pathogenesis. J Korean Med Sci. 29:2–11. 2014. View Article : Google Scholar : PubMed/NCBI | |
Gao B, Lee SM, Chen A, Zhang J, Zhang DD, Kannan K, Ortmann RA and Fang D: Synoviolin promotes IRE1 ubiquitination and degradation in synovial fibroblasts from mice with collagen-induced arthritis. EMBO Rep. 9:480–485. 2008. View Article : Google Scholar : PubMed/NCBI | |
Connor AM, Mahomed N, Gandhi R, Keystone EC and Berger SA: TNFα modulates protein degradation pathways in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther. 14:R622012. View Article : Google Scholar : PubMed/NCBI | |
Amano T, Yamasaki S, Yagishita N, Tsuchimochi K, Shin H, Kawahara K, Aratani S, Fujita H, Zhang L, Ikeda R, et al: Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy. Genes Dev. 17:2436–2449. 2003. View Article : Google Scholar : PubMed/NCBI | |
Yamasaki S, Yagishita N, Sasaki T, Nakazawa M, Kato Y, Yamadera T, Bae E, Toriyama S, Ikeda R, Zhang L, et al: Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase ‘Synoviolin’. Embo J. 26:113–122. 2007. View Article : Google Scholar : PubMed/NCBI | |
Yamasaki S, Yagishita N, Nishioka K and Nakajima T: The roles of synoviolin in crosstalk between endoplasmic reticulum stress-induced apoptosis and p53 pathway. Cell Cycle. 6:1319–1323. 2007. View Article : Google Scholar : PubMed/NCBI | |
Toh ML, Marotte H, Blond JL, Jhumka U, Eljaafari A, Mougin B and Miossec P: Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment. Arthritis Rheum. 54:2109–2118. 2006. View Article : Google Scholar : PubMed/NCBI | |
Klaasen R, Wijbrandts CA, van Kuijk AW, Pots D, Gerlag DM and Tak PP: Synovial synoviolin in relation to response to TNF blockade in patients with rheumatoid arthritis and psoriatic arthritis. Ann Rheum Dis. 71:1260–1261. 2012. View Article : Google Scholar : PubMed/NCBI | |
Yagishita N, Yamasaki S, Nishioka K and Nakajima T: Synoviolin, protein folding and the maintenance of joint homeostasis. Nat Clin Pract Rheumatol. 4:91–97. 2008. View Article : Google Scholar : PubMed/NCBI | |
Hasegawa D, Fujii R, Yagishita N, Matsumoto N, Aratani S, Izumi T, Azakami K, Nakazawa M, Fujita H, Sato T, et al: E3 ubiquitin ligase synoviolin is involved in liver fibrogenesis. PLoS One. 5:e135902010. View Article : Google Scholar : PubMed/NCBI | |
Wu T, Zhao F, Gao B, Tan C, Yagishita N, Nakajima T, Wong PK, Chapman E, Fang D and Zhang DD: Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis. Genes Dev. 28:708–722. 2014. View Article : Google Scholar : PubMed/NCBI | |
Nakajima F, Aratani S, Fujita H, Yagishita N, Ichinose S, Makita K, Setoguchi Y and Nakajima T: Synoviolin inhibitor LS-102 reduces endoplasmic reticulum stress-induced collagen secretion in an in vitro model of stress-related interstitial pneumonia. Int J Mol Med. 35:110–116. 2015. View Article : Google Scholar : PubMed/NCBI | |
Fujita H, Yagishita N, Aratani S, Saito-Fujita T, Morota S, Yamano Y, Hansson MJ, Inazu M, Kokuba H, Sudo K, et al: The E3 ligase synoviolin controls body weight and mitochondrial biogenesis through negative regulation of PGC-1β. EMBO J. 34:1042–1055. 2015. View Article : Google Scholar : PubMed/NCBI | |
Yagishita N, Aratani S, Leach C, Amano T, Yamano Y, Nakatani K, Nishioka K and Nakajima T: RING-finger type E3 ubiquitin ligase inhibitors as novel candidates for the treatment of rheumatoid arthritis. Int J Mol Med. 30:1281–1286. 2012. View Article : Google Scholar : PubMed/NCBI | |
Arita K, Hashimoto H, Shimizu T, Nakashima K, Yamada M and Sato M: Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol. 11:777–783. 2004. View Article : Google Scholar : PubMed/NCBI | |
Knuckley B, Bhatia M and Thompson PR: Protein arginine deiminase 4: Evidence for a reverse protonation mechanism. Biochemistry. 46:6578–6587. 2007. View Article : Google Scholar : PubMed/NCBI | |
Vossenaar ER, Nijenhuis S, Helsen MM, Van der Heijden A, Senshu T, van den Berg WB, van Venrooij WJ and Joosten LA: Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum. 48:2489–2500. 2003. View Article : Google Scholar : PubMed/NCBI | |
Raijmakers R, Zendman AJ, Egberts WV, Vossenaar ER, Raats J, Soede-Huijbregts C, Rutjes FP, van Veelen PA, Drijfhout JW and Pruijn GJ: Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. J Mol Biol. 367:1118–1129. 2007. View Article : Google Scholar : PubMed/NCBI | |
Butler PL, Staruschenko A and Snyder PM: Acetylation stimulates the epithelial sodium channel by reducing its ubiquitination and degradation. J Biol Chem. 290:12497–13503. 2015. View Article : Google Scholar : PubMed/NCBI | |
Rondas D, Crèvecoeur I, D'Hertog W, Ferreira GB, Staes A, Garg AD, Eizirik DL, Agostinis P, Gevaert K, Overbergh L and Mathieu C: Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes. Diabetes. 64:573–586. 2015. View Article : Google Scholar : PubMed/NCBI | |
Skriner K, Adolph K, Jungblut PR and Burmester GR: Association of citrullinated proteins with synovial exosomes. Arthritis Rheum. 54:3809–3814. 2006. View Article : Google Scholar : PubMed/NCBI | |
Goëb V, Thomas-L'Otellier M, Daveau R, Charlionet R, Fardellone P, Le Loët X, Tron F, Gilbert D and Vittecoq O: Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes. Arthritis Res Ther. 11:R382009. View Article : Google Scholar : PubMed/NCBI | |
Yamasaki S, Yagishita N, Tsuchimochi K, Kato Y, Sasaki T, Amano T, Beppu M, Aoki H, Nakamura H, Nishioka K and Nakajima T: Resistance to endoplasmic reticulum stress is an acquired cellular characteristic of rheumatoid synovial cells. Int J Mol Med. 18:113–117. 2006.PubMed/NCBI | |
Yao H, Li P, Venters BJ, Zheng S, Thompson PR, Pugh BF and Wang Y: Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis. J Biol Chem. 283:20060–20068. 2008. View Article : Google Scholar : PubMed/NCBI | |
Li P, Yao H, Zhang Z, Li M, Luo Y, Thompson PR, Gilmour DS and Wang Y: Regulation of p53 target gene expression by peptidylarginine deiminase 4. Mol Cell Biol. 28:4745–4758. 2008. View Article : Google Scholar : PubMed/NCBI | |
Tanikawa C, Espinosa M, Suzuki A, Masuda K, Yamamoto K, Tsuchiya E, Ueda K, Daigo Y, Nakamura Y and Matsuda K: Regulation of histone modification and chromatin structure by the p53-PADI4 pathway. Nat Commun. 3:6762012. View Article : Google Scholar : PubMed/NCBI | |
Liu GY, Liao YF, Chang WH, Liu CC, Hsieh MC, Hsu PC, Tsay GJ and Hung HC: Overexpression of peptidylarginine deiminase IV features in apoptosis of haematopoietic cells. Apoptosis. 11:183–196. 2006. View Article : Google Scholar : PubMed/NCBI | |
Seri Y, Shoda H, Suzuki A, Matsumoto I, Sumida T, Fujio K and Yamamoto K: Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model. Sci Rep. 5:130412015. View Article : Google Scholar : PubMed/NCBI | |
Moran M, Fang C and Paul A: Rheumatoid arthritis presenting as an invasive soft-tissue tumour. Arch Orthop Trauma Surg. 122:538–540. 2002. View Article : Google Scholar : PubMed/NCBI | |
Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K and Nishioka K: Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum. 38:485–491. 1995. View Article : Google Scholar : PubMed/NCBI | |
Nobunaga M: Malignant rheumatoid arthritis. Nihon Rinsho. 50:597–602. 1992.(In Japanese). PubMed/NCBI | |
Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, Friday S, Li S, Patel RM, Subramanian V, et al: NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 5:178ra402013. View Article : Google Scholar : PubMed/NCBI | |
Dwivedi N, Upadhyay J, Neeli I, Khan S, Pattanaik D, Myers L, Kirou KA, Hellmich B, Knuckley B, Thompson PR, et al: Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps. Arthritis Rheum. 64:982–992. 2012. View Article : Google Scholar : PubMed/NCBI | |
Spengler J, Lugonja B, Ytterberg A Jimmy, Zubarev RA, Creese AJ, Pearson MJ, Grant MM, Milward M, Lundberg K, Buckley CD, et al: Release of active peptidyl arginine deiminases by neutrophils can explain production of extracellular citrullinated autoantigens in rheumatoid arthritis synovial fluid. Arthritis Rheumatol. 67:3135–3145. 2015. View Article : Google Scholar : PubMed/NCBI | |
Li L, Shen Y, Ding Y, Liu Y, Su D and Liang X: Hrd1 participates in the regulation of collagen I synthesis in renal fibrosis. Mol Cell Biochem. 386:35–44. 2014. View Article : Google Scholar : PubMed/NCBI | |
Toh ML, Gonzales G, Koenders MI, Tournadre A, Boyle D, Lubberts E, Zhou Y, Firestein GS, van den Berg WB and Miossec P: Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression. PLoS One. 5:e134162010. View Article : Google Scholar : PubMed/NCBI | |
Burr ML, van den Boomen DJ, Bye H, Antrobus R, Wiertz EJ and Lehner PJ: MHC class I molecules are preferentially ubiquitinated on endoplasmic reticulum luminal residues during HRD1 ubiquitin E3 ligase-mediated dislocation. Proc Natl Acad Sci USA. 110:pp. 14290–14295. 2013; View Article : Google Scholar : PubMed/NCBI | |
Bianchini E, Fanin M, Mamchaoui K, Betto R and Sandonà D: Unveiling the degradative route of the V247M α-sarcoglycan mutant responsible for LGMD-2D. Hum Mol Genet. 23:3746–3758. 2014. View Article : Google Scholar : PubMed/NCBI |